Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 240

1.

Antibodies to interleukin 12 abrogate established experimental colitis in mice.

Neurath MF, Fuss I, Kelsall BL, Stüber E, Strober W.

J Exp Med. 1995 Nov 1;182(5):1281-90.

2.

Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12.

Duchmann R, Schmitt E, Knolle P, Meyer zum Büschenfelde KH, Neurath M.

Eur J Immunol. 1996 Apr;26(4):934-8.

PMID:
8625991
3.

Evidence for the critical role of interleukin-12 but not interferon-gamma in the pathogenesis of experimental colitis in mice.

Tozawa K, Hanai H, Sugimoto K, Baba S, Sugimura H, Aoshi T, Uchijima M, Nagata T, Koide Y.

J Gastroenterol Hepatol. 2003 May;18(5):578-87.

PMID:
12702051
4.

Interleukin 16 is up-regulated in Crohn's disease and participates in TNBS colitis in mice.

Keates AC, Castagliuolo I, Cruickshank WW, Qiu B, Arseneau KO, Brazer W, Kelly CP.

Gastroenterology. 2000 Oct;119(4):972-82.

PMID:
11040184
5.
6.

Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance.

Neurath MF, Fuss I, Kelsall BL, Presky DH, Waegell W, Strober W.

J Exp Med. 1996 Jun 1;183(6):2605-16.

7.

Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.

Lee J, Lee EN, Kim EY, Park HJ, Chang CY, Jung DY, Choi SY, Lee SK, Lee KW, Kwon GY, Joh JW, Kim SJ.

Immunol Lett. 2005 Nov 15;101(2):210-6.

PMID:
16026855
8.

Role of interleukin-12 in the induction of mucosal inflammation and abrogation of regulatory T cell function in chronic experimental colitis.

Liu Z, Geboes K, Heremans H, Overbergh L, Mathieu C, Rutgeerts P, Ceuppens JL.

Eur J Immunol. 2001 May;31(5):1550-60.

9.

Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice.

Fuss IJ, Marth T, Neurath MF, Pearlstein GR, Jain A, Strober W.

Gastroenterology. 1999 Nov;117(5):1078-88.

PMID:
10535870
10.

Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.

Abad C, Martinez C, Juarranz MG, Arranz A, Leceta J, Delgado M, Gomariz RP.

Gastroenterology. 2003 Apr;124(4):961-71.

PMID:
12671893
11.

Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice.

Neurath MF, Fuss I, Pasparakis M, Alexopoulou L, Haralambous S, Meyer zum Büschenfelde KH, Strober W, Kollias G.

Eur J Immunol. 1997 Jul;27(7):1743-50.

PMID:
9247586
12.

IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice.

Davidson NJ, Hudak SA, Lesley RE, Menon S, Leach MW, Rennick DM.

J Immunol. 1998 Sep 15;161(6):3143-9.

14.

Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease.

Kanai T, Watanabe M, Okazawa A, Sato T, Yamazaki M, Okamoto S, Ishii H, Totsuka T, Iiyama R, Okamoto R, Ikeda M, Kurimoto M, Takeda K, Akira S, Hibi T.

Gastroenterology. 2001 Oct;121(4):875-88.

PMID:
11606501
15.

The in vitro anti-inflammatory effects of recombinant anti-CD25 immunotoxin on lamina propria T cells of patients with inflammatory bowel disease are not sufficient to cure experimental colitis in mice.

Pfister K, Wittig BM, Jüngling B, Ecker KW, Barth S, Huhn M, Sasse S, Engert A, Mueller-Molaian I, Diehl V, Zeitz M, Stallmach A.

Int J Colorectal Dis. 2002 Mar;17(2):77-84.

PMID:
12014425
16.

Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.

Elson CO, Beagley KW, Sharmanov AT, Fujihashi K, Kiyono H, Tennyson GS, Cong Y, Black CA, Ridwan BW, McGhee JR.

J Immunol. 1996 Sep 1;157(5):2174-85.

PMID:
8757344
17.

Protection of trinitrobenzene sulfonic acid-induced colitis by an interleukin 2-IgG2b fusion protein in mice.

Stallmach A, Wittig B, Giese T, Pfister K, Hoffmann JC, Bulfone-Paus S, Kunzendorf U, Meuer SC, Zeitz M.

Gastroenterology. 1999 Oct;117(4):866-76.

PMID:
10500069
18.

CD45RChighCD4+ intestinal mucosal lymphocytes infiltrating in the inflamed colonic mucosa of a novel rat colitis model induced by TNB immunization.

Watanabe M, Hosoda Y, Okamoto S, Yamazaki M, Inoue N, Ueno Y, Iwao Y, Ishii H, Watanabe N, Hamada Y, Yamada T, Suzuki T, Hibi T.

Clin Immunol Immunopathol. 1998 Jul;88(1):46-55.

PMID:
9683549
20.

Mice deficient in Th1- and Th2-type cytokines develop distinct forms of hapten-induced colitis.

Dohi T, Fujihashi K, Kiyono H, Elson CO, McGhee JR.

Gastroenterology. 2000 Sep;119(3):724-33.

PMID:
10982767
Items per page

Supplemental Content

Write to the Help Desk